Results 251 to 260 of about 1,391,378 (297)
Some of the next articles are maybe not open access.
Pharmaceutisch Weekblad Scientific Edition, 1990
A receptor site is considered to be a transducing factor for effect of the natural ligand. Endorphins and the drugs that mimic their effects (the opiates) are important for analgesia, and consequently the receptor sites involved in actions of opioid drugs are to be considered as relevant to the transmission of pain.
openaire +2 more sources
A receptor site is considered to be a transducing factor for effect of the natural ligand. Endorphins and the drugs that mimic their effects (the opiates) are important for analgesia, and consequently the receptor sites involved in actions of opioid drugs are to be considered as relevant to the transmission of pain.
openaire +2 more sources
Current Protocols in Pharmacology, 1998
AbstractOpioid receptors mediate the pharmacologic actions of morphine‐like analgesics, a class of drugs that are important clinical agents which are also widely abused socially as a result of their euphorogenic and addictive properties. Cloning of the opioid receptors has confirmed the original postulate that there are only three classes of opioid ...
openaire +2 more sources
AbstractOpioid receptors mediate the pharmacologic actions of morphine‐like analgesics, a class of drugs that are important clinical agents which are also widely abused socially as a result of their euphorogenic and addictive properties. Cloning of the opioid receptors has confirmed the original postulate that there are only three classes of opioid ...
openaire +2 more sources
2015
The human μ-opioid receptor gene (OPRM1), due to its genetic and structural variation, has been a target of interest in several pharmacogenetic studies. The μ-opioid receptor (MOR), encoded by OPRM1, con- tributes to regulate the analgesic response to pain and also controls the rewarding effects of many drugs of abuse, including opioids, nicotine, and ...
openaire +2 more sources
The human μ-opioid receptor gene (OPRM1), due to its genetic and structural variation, has been a target of interest in several pharmacogenetic studies. The μ-opioid receptor (MOR), encoded by OPRM1, con- tributes to regulate the analgesic response to pain and also controls the rewarding effects of many drugs of abuse, including opioids, nicotine, and ...
openaire +2 more sources
Opioid receptors and opioid pharmacodynamics
2005Abstract Opioids have a long and rich pharmacology. They are widely used throughout medicine and have been invaluable. However, they come with problems, including side effects such as constipation, respiratory depression and sedation, as well as the potential of abuse.
Mellar P Davis, Gavril W Pasternak
openaire +1 more source
1990
Abstract Evidence for the heterogeneity of opioid receptor sites in the CNS has been provided by a variety of studies. At least three classes of binding sites have been identified and designated as μ (morphine), δ (enkephalin) and x (dynorphin).
Catherine D Demoliou-mason +1 more
openaire +1 more source
Abstract Evidence for the heterogeneity of opioid receptor sites in the CNS has been provided by a variety of studies. At least three classes of binding sites have been identified and designated as μ (morphine), δ (enkephalin) and x (dynorphin).
Catherine D Demoliou-mason +1 more
openaire +1 more source
CLASSIFICATION OF OPIOID RECEPTORS
British Medical Bulletin, 1983S J, Paterson +2 more
openaire +2 more sources
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Cell, 2018Brian Krumm +2 more
exaly